Welcome back Rounds Table listeners!
We are returning with a throwback!
In this repeat episode, Mike and John do a Rapid Fire session on recent papers exploring the addition of LAMAs in asthma management and treatment durations for UTIs in men. Here we go!
- Does adding a long-acting muscarinic antagonist to inhaled corticosteroids and long-acting β2-agonists improve outcomes among individuals with moderate to severe persistent asthma?
- Is 7 days vs 14 days non-inferior to treat urinary tract infections in afebrile men?
And for the good stuff:
